- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
9
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
9 companies
Merck
Market Cap: US$206.8b
Operates as a healthcare company worldwide.
MRK
US$82.81
7D
-1.5%
1Y
-29.8%
Waters
Market Cap: US$17.6b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$295.39
7D
-4.5%
1Y
-10.1%
Agios Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$36.78
7D
1.0%
1Y
-19.0%
CureVac
Market Cap: US$1.2b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$5.34
7D
-0.2%
1Y
63.3%
SIGA Technologies
Market Cap: US$638.7m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.92
7D
3.0%
1Y
11.6%
CytomX Therapeutics
Market Cap: US$329.8m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$2.00
7D
-8.3%
1Y
65.3%
Abeona Therapeutics
Market Cap: US$329.7m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$6.43
7D
-4.0%
1Y
20.6%
Puma Biotechnology
Market Cap: US$225.2m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$4.47
7D
-2.0%
1Y
77.4%
Coherus Oncology
Market Cap: US$149.9m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.29
7D
-5.8%
1Y
22.9%